Medigene AG (HAM:MDG1) FFO


HAM:MDG1 Medigene AG HAM:MDG1
12 GF Score
Price €0.02
View Full Analysis

What is Medigene AG FFO?

FFO (Funds from operations) only applies to REITs.

HAM:MDG1
12GF Score
Medigene AG HAM:MDG1
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medigene AG Business Description

Address Lochhamer Strasse 11, Martinsried, Planegg, BY, DEU, 82152
Medigene AG is an immuno-oncology biotechnology company. focused on developing differentiated T Cell Receptor engineered T cell (TCR-T) therapies for the treatment of multiple solid tumor indications with a high unmet medical need. The operating segments of the organization are Immunotherapies and Other products. Immunotherapies consist of T-cell receptor-based adoptive T-cell therapy and DC vaccines. The group operates in the United States, Germany, and Asia, of which the majority of the revenue is derived from operations in Germany.
12GF Score

Get the complete analysis for HAM:MDG1

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.02
Price